ADRs End Higher, Aesthetic Medical International Holdings Group Ltd. Climbs 35.5%
This article was automatically generated by Dow Jones Newswires using technology from Automated Insights.
International stocks trading in New York closed higher on Wednesday. The S&P/BNY Mellon index of American depositary receipts rose 0.6% to 178.30.
The European index gained 0.6% to 173.14. The Asian index increased 0.5% to 207.85. The Latin American index added 0.3% to 214.41, while the emerging-markets index gained 0.4% to 332.08.
China's Aesthetic Medical International Holdings Group Ltd. was the biggest leader during the session, soaring 35.5% to 46 cents. U.K.-based Barinthus Biotherapeutics PLC rose 22.8% to $2.91. Akso Health Group, which is based in China, rounded out the top three leaders on Wednesday, with shares rising 20.9% to $1.33.
Moatable Inc., based in China, posted the largest decline, plummeting 30.6% to 45 cents, followed by shares of the U.K.'s Biodexa Pharmaceuticals PLC, which plunged 19.1% to $1.10. Shares of China-based Emeren Group Ltd. fell 17.0% to $1.96.
Data source: Dow Jones Market Data, FactSet.
(END) Dow Jones Newswires
April 03, 2024 17:11 ET (21:11 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Paramount Earnings: CEO Has Gone, For-Sale Sign Is Up; Good Results Would’ve Been Nice to Learn
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure